TC BioPharm Email Format
Biotechnology ResearchScotland, United Kingdom11-50 Employees
TC BioPharm is a clinical-stage biotechnology company based in Scotland that develops cell therapies for cancer and infectious diseases. It specializes in allogeneic CAR-T therapies and gamma delta T cell therapies, pursuing off-the-shelf approaches intended to address manufacturing and accessibility challenges in treatment. The company maintains a growing team in Glasgow and works with a network of scientific advisers and partner organisations. It is publicly traded. TC BioPharm serves the oncology and infectious disease research and healthcare communities seeking new therapeutic options. A recent development includes a collaboration with Carnegie Mellon University to create an artificial intelligence solution to improve donor screening and matching for cell therapy.